Issue 9/2019
Content (22 Articles)
Hypophosphatasia: Canadian update on diagnosis and management
A.A. Khan, R. Josse, P. Kannu, J. Villeneuve, T. Paul, S. Van Uum, C.R. Greenberg
Efficacy and safety of elcatonin in postmenopausal women with osteoporosis: a systematic review with network meta-analysis of randomized clinical trials
W.-C. Chen, E.-Y. Lin, Y.-N. Kang
Fracture risk following intermission of osteoporosis therapy
E.M. Dennison, C. Cooper, J.A. Kanis, O. Bruyère, S. Silverman, E. McCloskey, B. Abrahamsen, D. Prieto-Alhambra, S. Ferrari
Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom
A. Svedbom, P. Hadji, E. Hernlund, R. Thoren, E. McCloskey, R. Stad, B. Stollenwerk
Biochemical markers of bone turnover and risk of incident hip fracture in older women: the Cardiovascular Health Study
D. Massera, S. Xu, M. D. Walker, R. J. Valderrábano, K. J. Mukamal, J. H. Ix, D. S. Siscovick, R. P. Tracy, J. A. Robbins, M. L. Biggs, X. Xue, J. R. Kizer
History of cardiovascular disease and cardiovascular biomarkers are associated with 30-day mortality in patients with hip fracture
D. Norring-Agerskov, C. M. Madsen, L. Bathum, O. B. Pedersen, J. B. Lauritzen, N. R. Jørgensen, H. L. Jørgensen
Secondary prevention of osteoporotic fractures: evaluation of the Lille University Hospital’s Fracture Liaison Service between January 2016 and January 2018
A. Pflimlin, A. Gournay, I. Delabrière, C. Chantelot, F. Puisieux, B. Cortet, J. Paccou
The association between prevalent vertebral fractures and bone quality of the distal radius and distal tibia as measured with HR-pQCT in postmenopausal women with a recent non-vertebral fracture at the Fracture Liaison Service
L. Vranken, C. E. Wyers, B. van Rietbergen, J. H. M. Driessen, P. P. M. M. Geusens, H. M. J. Janzing, R. Y. van der Velde, J. P. W. van den Bergh
Bone mineral density in diabetes and impaired fasting glucose
K. L. Holloway-Kew, N. Marijanovic, L. L. F. De Abreu, M. A. Sajjad, J. A. Pasco, M. A. Kotowicz
Bone mass density and bone metabolism marker are associated with progression of carotid and cardiac calcified plaque in Chinese elderly population
D. Liu, L. Chen, S. Dong, Z. Peng, H. Yang, Y. Chen, L. Li, H. Zhou, R. Zhou
Use of anti-osteoporosis medication dispensing by patients with hip fracture: could we do better?
P. K. Kristensen, V. Ehrenstein, N. Shetty, A. B. Pedersen
The combined effect of Parathyroid hormone (1–34) and whole-body Vibration exercise in the treatment of postmenopausal OSteoporosis (PaVOS study): a randomized controlled trial
D. B. Jepsen, J. Ryg, S. Hansen, N. R. Jørgensen, J. Gram, T. Masud
Two-year persistence with teriparatide improved significantly after introduction of an educational and motivational support program
M.A. van Maren, C.E. Wyers, J.H.M. Driessen, J.V. Visser, F. de Vries, K. van de Wijdeven, S. Gevers, W.F. Lems, M.H. Emmelot-Vonk, J.P.W. van den Bergh
Saving bones without risking brain—bisphosphonates and risk of stroke: matched case-control study
Z. B. Asghar, A. Godoy Caballero, S. Pathirannehelage, J. Williams, S. McKay, P. Grassby, S. de Lusignan, A. Niroshan Siriwardena
Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group
J.P. Bilezikian, C.J.F. Lin, J.P. Brown, A.T. Wang, X. Yin, P.R. Ebeling, A. Fahrleitner-Pammer, E. Franek, N. Gilchrist, P.D. Miller, J.A. Simon, I. Valter, C.A.F. Zerbini, C. Libanati, A. Chines
Denosumab utilization among older adults in Ontario: patient characteristics, persistence with therapy, and return to therapy after an extended gap
J.K. Ban, B.B. Hao, L. McCarthy, S.J.T. Guilcher, S.M. Cadarette
WNT3A accelerates delayed alveolar bone repair in ovariectomized mice
Y. Liu, Z. Li, M. Arioka, L. Wang, C. Bao, J.A. Helms
Nutritional hypophosphatemic rickets secondary to Neocate® use
S. Akhtar Ali, A. Mathalikunnel, V. Bhardwaj, M. Braskett, P. Pitukcheewanont
Diffuse, fracturing systemic skeletal histiocytosis of unknown type: a novel metabolic bone disease
R. Saini, L. M. DiFrancesco, K. Johnston, A. Khan, G. A. Kline
Correction to: The factor-of-risk biomechanical approach predicts hip fracture in men and women: the Framingham Study
A.B. Dufour, B. Roberts, K.E. Broe, D.P. Kiel, M.L. Bouxsein, M.T. Hannan
Correction to: Secondary prevention of osteoporotic fractures: evaluation of the Lille University Hospital’s Fracture Liaison Service between January 2016 and January 2018
A. Pflimlin, A. Gournay, I. Delabrière, C. Chantelot, F. Puisieux, B. Cortet, J. Paccou
Correction to: Prevalent vertebral fractures and minor vertebral deformities analyzed by vertebral fracture assessment (VFA) increases the risk of incident fractures in postmenopausal women: the FRODOS study
E. Kanterewicz, E. Puigoriol, J.R. Rodríguez Cros, P. Peris